<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tblu7" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Groups</th><th>Variance estimate</th><th>F test statistic <break/>F(1,64) <break/>(shRNA, Dox)</th><th>Partial &#951;<sup>2</sup></th><th>Effect size <italic>f</italic></th><th>A priori power</th><th>Total sample <break/>size <break/>(32 groups)</th></tr></thead><tbody><tr><td rowspan="4">Normalized pMEK <break/>in shBRAF or shCRAF <break/>cells treated with or <break/>without Dox across <break/>varying&#160;doses of <break/>GDC-0879</td><td>2%</td><td>327.18</td><td>0.83639</td><td>2.26101</td><td>99.9%</td><td>96</td></tr><tr><td>15%</td><td>5.81651</td><td>0.08331</td><td>0.30147</td><td>82.9%</td><td>96</td></tr><tr><td>28%</td><td>1.66928</td><td>0.02542</td><td>0.16150</td><td>82.1%</td><td>320</td></tr><tr><td>40%</td><td>0.81795</td><td>0.01262</td><td>0.11305</td><td>81.5%</td><td>640</td></tr><tr><td rowspan="4">Normalized pMEK <break/>in shBRAF or <break/>shCRAF cells treated <break/>with or&#160;without Dox <break/>across&#160;varying doses <break/>of&#160;PLX4720</td><td>2%</td><td>7267.4</td><td>0.99127</td><td>10.6561</td><td>99.9%</td><td>96</td></tr><tr><td>15%</td><td>129.198</td><td>0.66873</td><td>1.42082</td><td>99.9%</td><td>96</td></tr><tr><td>28%</td><td>37.0786</td><td>0.36683</td><td>0.76115</td><td>99.9%</td><td>96</td></tr><tr><td>40%</td><td>18.1685</td><td>0.22111</td><td>0.53281</td><td>99.9%</td><td>96</td></tr></tbody></table></table-wrap>